15 Nov 2017 11:47
Surgical Innovations Group plc
(the "Company")
Â
Director/PDMR Shareholding
Â
The Company was notified on 14 November 2017 that Adam Power, Group Development Director, had made the following purchases of ordinary shares of 1 penny each in the Company ("Shares") for his family.
Â
Date | No. of Shares | Price |
27 September 2017 | 27,612 | 3.6p |
10 November 2017 | 29,690 | 3.348p |
Â
Following the purchases, the beneficial holding of Adam Power is 31,307,302 Shares, representing approximately 4.0% of the issued share capital of the Company.
Â
The information below, set out in accordance with the requirements of the EU Market Abuse
Regulation, provides further detail on shares acquired.
Â
For further information please contact:
Â
Surgical Innovations Group plc | www.sigroupplc.com |
Nigel Rogers, Executive Chairman | Tel: 0113 230 7597 |
Melanie Ross, COO & CFO | Â |
 |  |
WH Ireland Limited (NOMAD & Broker) | Tel: 0113 394 6600 |
Tim Feather Alex Bond | Â |
 |  |
Walbrook PR (Financial PR & Investor Relations) | Tel: 020 7933 8780 or si@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
Â
Â
Â
Â
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name | Adam Power | |||
2 | Reason for the notification | ||||
a) | Position/status | Group Development Director, Surgical Innovations Group plc | |||
b) | Initial notification/ Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Surgical Innovations Group plc | |||
b) | LEI | 2138004GHGUH3HUZE156 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument  Identification code | Ordinary shares of 1p    GB0004016704 | |||
b) | Nature of the transactions | Purchases of Ordinary Shares | |||
c) | Price(s) and volume(s) | Â | Price(s) | Volume(s) | Â |
3.6p | 27,612 | ||||
 | |||||
d) | Aggregated information - Aggregated volume - Price | Â 27,612 ÂĢ994 | |||
e) | Date of the transaction | 27 September 2017 | |||
f) | Place of the transaction | London Stock Exchange, AIM | |||
Â
Â
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name | Adam Power | |||
2 | Reason for the notification | ||||
a) | Position/status | Group Development Director, Surgical Innovations Group plc | |||
b) | Initial notification/ Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Surgical Innovations Group plc | |||
b) | LEI | 2138004GHGUH3HUZE156 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument  Identification code | Ordinary shares of 1p    GB0004016704 | |||
b) | Nature of the transactions | Purchases of Ordinary Shares | |||
c) | Price(s) and volume(s) | Â | Price(s) | Volume(s) | Â |
 | 3.348p | 29,690 |  | ||
 | |||||
d) | Aggregated information - Aggregated volume - Price | Â 29,690 ÂĢ994 | |||
e) | Date of the transaction | 10 November 2017 | |||
f) | Place of the transaction | London Stock Exchange, AIM | |||
Â
Follow the stocks